{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:12:52Z","timestamp":1773965572684,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.clnu.2024.10.024","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T15:50:28Z","timestamp":1729698628000},"page":"233-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of N-3 fatty acids supplementation on spondyloarthritis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0476-154X","authenticated-orcid":false,"given":"Elpida","family":"Skouvaklidou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xenophon","family":"Theodoridis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Tziona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Periklis","family":"Vounotrypidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros","family":"Dimitroulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michail","family":"Chourdakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clnu.2024.10.024_bib1","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00005792-197409000-00002","article-title":"Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome","volume":"53","author":"Moll","year":"1974","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.clnu.2024.10.024_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41584-020-00552-4","article-title":"Axial spondyloarthritis: concept, construct, classification and implications for therapy","volume":"17","author":"Robinson","year":"2021","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.clnu.2024.10.024_bib3","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2009.108217","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.clnu.2024.10.024_bib4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.clnu.2024.10.024_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/ard.2010.133645","article-title":"The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general","volume":"70","author":"Rudwaleit","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.clnu.2024.10.024_bib6","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.clnu.2024.10.024_bib7","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/acr.22831","article-title":"Global prevalence of spondyloarthritis: a systematic review and meta-regression analysis","volume":"68","author":"Stolwijk","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.clnu.2024.10.024_bib8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.clnu.2024.10.024_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2021-222020","article-title":"2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases","volume":"82","author":"Gwinnutt","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.clnu.2024.10.024_bib10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/intimm\/dxz001","article-title":"Omega-3 fatty acid-derived mediators that control inflammation and tissue homeostasis","volume":"31","author":"Ishihara","year":"2019","journal-title":"Int Immunol"},{"issue":"12","key":"10.1016\/j.clnu.2024.10.024_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/nu11122990","article-title":"The influence of dietary fatty acids on immune responses","volume":"11","author":"Radzikowska","year":"2019","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.clnu.2024.10.024_bib12","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.arcmed.2012.06.011","article-title":"Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis","volume":"43","author":"Lee","year":"2012","journal-title":"Arch Med Res"},{"key":"10.1016\/j.clnu.2024.10.024_bib13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.nut.2017.06.023","article-title":"Intake of \u03c9-3 polyunsaturated fatty acids in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"45","author":"Gioxari","year":"2018","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.clnu.2024.10.024_bib14","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/10408398.2022.2104210","article-title":"Efficacy of n-3 fatty acid supplementation on rheumatoid arthritis' disease activity indicators: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"64","author":"Gkiouras","year":"2024","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"7","key":"10.1016\/j.clnu.2024.10.024_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.clnu.2024.10.024_bib16","series-title":"Cochrane Handbook for systematic reviews of interventions","first-page":"1","author":"Higgins","year":"2019"},{"issue":"1","key":"10.1016\/j.clnu.2024.10.024_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"7829","key":"10.1016\/j.clnu.2024.10.024_bib18","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.clnu.2024.10.024_bib19","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/rheumatology\/38.9.878","article-title":"Defining disease activity in ankylosing spondylitis: is a combination of variables (Bath Ankylosing Spondylitis Disease Activity Index) an appropriate instrument?","volume":"38","author":"Calin","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.clnu.2024.10.024_bib20","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","article-title":"Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis","volume":"68","author":"Lukas","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.clnu.2024.10.024_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","article-title":"Measurement of patient outcome in arthritis","volume":"23","author":"Fries","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"10.1016\/j.clnu.2024.10.024_bib22","article-title":"The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis","volume":"68","author":"Sieper","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.clnu.2024.10.024_bib23","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1080\/00365520410009429","article-title":"Reduced joint pain after short-term duodenal administration of seal oil in patients with inflammatory bowel disease: comparison with soy oil","volume":"39","author":"Bj\u00f8rkkj\u00e6r","year":"2004","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.clnu.2024.10.024_bib24","first-page":"307","article-title":"Subjective improvement in patients with psoriatic arthritis after short-term oral treatment with seal oil. A pilot study with double blind comparison to soy oil","volume":"33","author":"Madland","year":"2006","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.clnu.2024.10.024_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/03009742.2017.1287304","article-title":"Beneficial effect of n-3 polyunsaturated fatty acids on inflammation and analgesic use in psoriatic arthritis: a randomized, double blind, placebo-controlled trial","volume":"47","author":"Kristensen","year":"2018","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"10.1016\/j.clnu.2024.10.024_bib26","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/rheumatology\/33.10.954","article-title":"A\u00a0double-blind placebo controlled trial of Efamol Marine on skin and joint symptoms of psoriatic arthritis","volume":"33","author":"Veale","year":"1994","journal-title":"Br J Rheumatol"},{"issue":"1","key":"10.1016\/j.clnu.2024.10.024_bib27","doi-asserted-by":"crossref","first-page":"30","DOI":"10.31138\/mjr.34.1.30","article-title":"Fly me to the immune: immunonutrition in rheumatic diseases","volume":"34","author":"Grammatikopoulou","year":"2023","journal-title":"Mediterr J Rheumatol"},{"issue":"1","key":"10.1016\/j.clnu.2024.10.024_bib28","article-title":"Effects of fish oil supplement on psoriasis: a meta-analysis of randomized controlled trials","volume":"19","author":"Yang","year":"2019","journal-title":"BMC Compl Alternative Med"},{"issue":"1","key":"10.1016\/j.clnu.2024.10.024_bib29","article-title":"Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys","volume":"348","author":"Micha","year":"2014","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.clnu.2024.10.024_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.plefa.2010.06.007","article-title":"Bioavailability of marine n-3 fatty acid formulations","volume":"83","author":"Dyerberg","year":"2010","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"18","key":"10.1016\/j.clnu.2024.10.024_bib31","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1080\/10408398.2021.1880364","article-title":"Bioavailability and conversion of plant based sources of omega-3 fatty acids \u2013 a scoping review to update supplementation options for vegetarians and vegans","volume":"62","author":"Lane","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"10.1016\/j.clnu.2024.10.024_bib32","doi-asserted-by":"crossref","DOI":"10.1186\/s42358-022-00243-6","article-title":"Dietetic intervention in psoriatic arthritis: the DIETA trial","volume":"62","author":"Leite","year":"2022","journal-title":"Adv Rheumatol"},{"issue":"5","key":"10.1016\/j.clnu.2024.10.024_bib33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/03009740600844357","article-title":"Supplementation of omega-3 fatty acids in patients with ankylosing spondylitis","volume":"35","author":"Sundstr\u00f6m","year":"2006","journal-title":"Scand J Rheumatol"},{"issue":"5\u20136","key":"10.1016\/j.clnu.2024.10.024_bib34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.plefa.2009.07.005","article-title":"A\u00a0randomized double blind comparison of short-term duodenally administrated whale and seal blubber oils in patients with inflammatory bowel disease and joint pain","volume":"81","author":"Bj\u00f8rkkj\u00e6r","year":"2009","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"4","key":"10.1016\/j.clnu.2024.10.024_bib35","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.clnu.2008.01.017","article-title":"Effects of short-term oral administration of dietary marine oils in patients with inflammatory bowel disease and joint pain: a pilot study comparing seal oil and cod liver oil","volume":"27","author":"Brunborg","year":"2008","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.clnu.2024.10.024_bib36","first-page":"68","article-title":"Effects of dietary supplementation with polyunsaturated ethyl ester lipids (Angiosan) in patients with psoriasis and psoriatic arthritis","volume":"18","author":"Lassus","year":"1990","journal-title":"J\u00a0Int Med Res"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424003820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561424003820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T12:22:27Z","timestamp":1738412547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561424003820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0261561424003820"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2024.10.024","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of N-3 fatty acids supplementation on spondyloarthritis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2024.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}